Human Microbiome Market: Focus on Therapeutics (including gut-brain axis targeting drugs

Market-Research

Key Inclusions

A detailed assessment of the current market landscape of microbiome therapeutics, providing information on drug / therapy developer(s) (such as year of establishment, location of headquarters and company size), clinical study sponsor(s) or

Submitted by Roots_Analysis on 2020-09-17 13:30.

Presently, 260 drug candidates are being evaluated in clinical / preclinical stages for the treatment

Market-Research

The concept of microbiome-based therapeutics has generated significant enthusiasm within the medical science community, defining a new frontier in the field of medicine. Despite having captured the interest of several venture capital firms and big pharma players, no microbiome-based therapeutic ... Read more

Submitted by Roots_Analysis on 2020-09-17 13:26.

Human Microbiome-based Products Market is projected to be worth USD 4 Billion by 2030

Market-Research

Roots Analysis has announced the addition of “Human Microbiome Market, 2019-2030” report to its list of

Submitted by Roots_Analysis on 2020-09-17 13:23.

Human Microbiome-based Products Market is projected to be worth USD 4 Billion by 2030

Market-Research

Over the years, extensive R&D efforts have enabled microbiome-based therapy / diagnostic developers to make significant strides, in terms of progressing proprietary product candidates into the clinic

Roots Analysis ... Read more

Submitted by Roots_Analysis on 2020-09-17 13:16.

Human Microbiome-based Products Market is projected to be worth USD 4 Billion by 2030

Market-Research

Over the years, extensive R&D efforts have established the basis for a wide range of microbiome-based therapeutic and diagnostic products, which may cause a paradigm shift in the way healthcare is delivered in the foreseen future

Submitted by Roots_Analysis on 2020-09-17 13:13.

In Silico / Computer-Aided Drug Discovery Services Market: Focus on Large Molecules (Antibodies, Proteins, Peptides, Nucleic Acid, Gene Therapy and Vectors), 2020-2030 (Including Structure Based Drug Discovery

Pharmaceuticals

To order this detailed 290+ page report, please visit this link

Key Inclusions

A detailed review of the overall

Submitted by Roots_Analysis on 2020-09-17 10:36.

90 firms are actively involved in providing in silico services for drug discovery of different types of biologics; of these, over 30 players claim to have the capabilities to offer services for all steps of discovery

Pharmaceuticals

Presently, in silico tools / approaches are available for the identification, selection and optimization of pharmacological leads. in fact, the predictive power of such solutions has been demonstrated to enable researchers to bypass the traditional experimental screening of billions of molecules ... Read more

Submitted by Roots_Analysis on 2020-09-17 10:35.

In silico drug discovery services market is likely to be worth USD 124 million by 2030, growing at an annualized rate of 15.6%, claims Roots Analysis

Pharmaceuticals

Roots Analysis has done a detailed study on “In Silico / Computer-Aided Drug Discovery Services Market: Focus on Large Molecules (Antibodies, Proteins, ... Read more

Submitted by Roots_Analysis on 2020-09-17 10:35.

In silico drug discovery services market is likely to be worth USD 124 million by 2030, growing at an annualized rate of 15.6%, claims Roots Analysis

Pharmaceuticals

Excessive capital requirement and myriad of other complexities associated with the discovery of biologics have prompted drug developers to adopt in silico tools / techniques to expedite the discovery timelines

Roots

Submitted by Roots_Analysis on 2020-09-17 10:33.

In silico drug discovery services market is likely to be worth USD 124 million by 2030, growing at an annualized rate of 15.6%, claims Roots Analysis

Market-Research

Owing to their cost and time saving potential, in silico tools are widely used in modern pharmacological research; several companies have developed novel tools, which are specifically designed to accelerate and augment the drug discovery process. ... Read more

Submitted by Roots_Analysis on 2020-09-17 10:32.

Human Microbiome Market: Focus on Therapeutics

Pharmaceuticals

To order this detailed 640+ page report, please visit this link

Key Inclusions

A detailed assessment of the

Submitted by Roots_Analysis on 2020-09-17 10:31.

Presently, 260 drug candidates are being evaluated in clinical / preclinical stages for the treatment of a wide variety of disease indications; the US has emerged as the major hub for microbiome-based research

Pharmaceuticals

Submitted by Roots_Analysis on 2020-09-17 10:30.

Human Microbiome-based Products Market is projected to be worth USD 4 Billion by 2030, growing at an annualized rate of over 40%, claims Roots Analysis

Pharmaceuticals

Roots Analysis has announced the addition of “Human Microbiome Market, 2019-2030” report to its list of offerings. ... Read more

Submitted by Roots_Analysis on 2020-09-17 10:02.

Human Microbiome-based Products Market is projected to be worth USD 4 Billion by 2030, growing at an annualized rate of over 40%, claims Roots Analysis

Pharmaceuticals

Roots Analysis ... Read more

Submitted by Roots_Analysis on 2020-09-17 10:00.

Human Microbiome-based Products Market is projected to be worth USD 4 Billion by 2030, growing at an annualized rate of over 40%, claims Roots Analysis

Pharmaceuticals

Submitted by Roots_Analysis on 2020-09-17 09:59.

The “HPAPI and Cytotoxic Drugs Manufacturing Market (3rd Edition), 2020-2030” report features an extensive study of the current market landscape, offering an informed opinion on the manufacturing of HPAPIs and cytotoxic drugs over the next decade.

Pharmaceuticals

To order this detailed 300+ page report, please visit this link

Key Inclusions

A detailed review

Submitted by Roots_Analysis on 2020-09-16 09:37.

Close to 120 companies across the globe claim to possess the required expertise and infrastructure to offer contract manufacturing services for HPAPIs and cytotoxic drugs, claims Roots Analysis

Market-Research

Development initiatives of HPAPIs and cytotoxic drugs are generally very demanding, both in terms of experience and capital investment. Most companies generally lack the necessary resources to meet the aforementioned requirements and are unable to set up dedicated HPAPI and cytotoxic drug ... Read more

Submitted by Roots_Analysis on 2020-09-16 09:37.

Growing at an annualized rate of 12%, the HPAPI and cytotoxic drugs contract manufacturing market is projected to reach USD 25 billion by 2030, claims Roots Analysis

Pharmaceuticals

Roots Analysis has done a detailed study on “HPAPI and Cytotoxic Drugs Manufacturing (3rd Edition) 2020- 2030”, covering key aspects of ... Read more

Submitted by Roots_Analysis on 2020-09-16 09:36.

Growing at an annualized rate of 12%, the HPAPI and cytotoxic drugs contract manufacturing market is projected to reach USD 25 billion by 2030, claims Roots Analysis

Market-Research

Manufacturing highly potent drug products is technically and financially demanding; as a result, drug manufacturers are becoming increasingly reliant on contract service providers

Roots Analysis is pleased to announce the ... Read more

Submitted by Roots_Analysis on 2020-09-16 09:35.

The “High Energy Chemistry / Hazardous Chemistry Services Market, 2020-2030” report features an extensive study on the current landscape and the likely future potential of the companies offering services for API manufacturing based on high energy chemistr

Pharmaceuticals

To order this detailed 240+ page report, please visit this link

Key Inclusions

§ ... Read more

Submitted by Roots_Analysis on 2020-09-16 09:35.

Pages